Literature DB >> 19150305

The platelet and platelet function testing in liver disease.

Greg G C Hugenholtz1, Robert J Porte2, Ton Lisman3.   

Abstract

Patients who have liver disease commonly present with alterations in platelet number and function. Recent data have questioned the contribution of these changes to bleeding complications in these patients. Modern tests of platelet function revealed compensatory mechanisms for the decreased platelet number and function, the most prominent compensatory mechanism being substantially elevated levels of the adhesive protein von Willebrand's factor. Consequently, standard diagnostic tests of platelet functions seem to be of little use to predict bleeding complication in patients who have liver disease. This article outlines the role of platelet abnormalities and possibilities for platelet function testing in patients who have liver disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150305     DOI: 10.1016/j.cld.2008.09.010

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  12 in total

1.  Joint Effects of GWAS SNPs in Coagulation System Confer Risk to Hypertensive Intracerebral Hemorrhage.

Authors:  Yanyan Cao; Min Tian; Qin Fang; Zheng Wen; Wei Wang; Hu Ding; Dao Wen Wang
Journal:  Neuromolecular Med       Date:  2017-07-17       Impact factor: 3.843

Review 2.  Surgery in a patient with liver disease.

Authors:  Rakesh Rai; Sanjay Nagral; Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

3.  Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study.

Authors:  Matthew A Warner; Arun Chandran; Ryan D Frank; Daryl J Kor
Journal:  Anesth Analg       Date:  2019-02       Impact factor: 5.108

Review 4.  Coagulopathy and transfusion therapy in pediatric liver transplantation.

Authors:  Mirco Nacoti; Davide Corbella; Francesco Fazzi; Francesca Rapido; Ezio Bonanomi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 5.  Management of acute liver failure.

Authors:  R Todd Stravitz; David J Kramer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

6.  The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.

Authors:  Ton Lisman; Virginia Hernandez-Gea; Maria Magnusson; Lara Roberts; Simon Stanworth; Jecko Thachil; Armando Tripodi
Journal:  J Thromb Haemost       Date:  2021-04       Impact factor: 5.824

7.  Management of coagulopathy in patients with decompensated liver cirrhosis.

Authors:  Pooja D Amarapurkar; Deepak N Amarapurkar
Journal:  Int J Hepatol       Date:  2011-11-17

8.  Thrombocytopenia in Patients with Gastric Varices and the Effect of Balloon-occluded Retrograde Transvenous Obliteration on the Platelet Count.

Authors:  W E Saad; W Bleibel; N Adenaw; C E Wagner; C Anderson; J F Angle; A M Al-Osaimi; M G Davies; S Caldwell
Journal:  J Clin Imaging Sci       Date:  2014-04-30

9.  Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis.

Authors:  Kakali Ghoshal; Maitree Bhattacharyya
Journal:  ScientificWorldJournal       Date:  2014-03-03

Review 10.  Perioperative thromboprophylaxis in liver transplant patients.

Authors:  Lesley De Pietri; Roberto Montalti; Daniele Nicolini; Roberto Ivan Troisi; Federico Moccheggiani; Marco Vivarelli
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.